• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Parallel epidemics, or nearly so: Certainties and uncertainties about SARS-CoV-2 in Italy.

作者信息

Gentile Sandro, Mambro Andrea, Strollo Felice

机构信息

Campania University "Luigi Vanvitelli, and Nefrocenter Research & Nyx Start-UP, Naples, Italy.

Anesthesiology and Resuscitation Unit, CTO, Andrea Alesini Hospital, Rome, Italy.

出版信息

Diabetes Res Clin Pract. 2020 Jun;164:108195. doi: 10.1016/j.diabres.2020.108195. Epub 2020 May 12.

DOI:10.1016/j.diabres.2020.108195
PMID:32407747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7214347/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/7214347/ffc98ee3b75c/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/7214347/9a836b74bc3c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/7214347/aa11229f95d0/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/7214347/99e48767cbb1/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/7214347/2d573e63085b/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/7214347/ffc98ee3b75c/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/7214347/9a836b74bc3c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/7214347/aa11229f95d0/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/7214347/99e48767cbb1/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/7214347/2d573e63085b/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf8/7214347/ffc98ee3b75c/gr5_lrg.jpg

相似文献

1
Parallel epidemics, or nearly so: Certainties and uncertainties about SARS-CoV-2 in Italy.平行疫情，或近乎如此：意大利境内关于新冠病毒的确定性与不确定性
Diabetes Res Clin Pract. 2020 Jun;164:108195. doi: 10.1016/j.diabres.2020.108195. Epub 2020 May 12.
2
Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.糖尿病是危重症患者下呼吸道样本中 SARS-CoV-2 病毒持续脱落的一个风险因素。
Endocrine. 2020 Dec;70(3):454-460. doi: 10.1007/s12020-020-02465-4. Epub 2020 Sep 1.
3
Importance of mitigation measures for hospital transmission of SARS-CoV-2 at the onset of the epidemic: the experience of Brescia, Northern Italy.疫情初期缓解措施对 SARS-CoV-2 医院传播的重要性：意大利北部布雷西亚的经验。
Infection. 2021 Dec;49(6):1241-1248. doi: 10.1007/s15010-021-01692-9. Epub 2021 Sep 15.
4
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021.2020 年 10 月至 2021 年 3 月意大利流行的 SARS-CoV-2 变异株。
Virol J. 2021 Aug 14;18(1):168. doi: 10.1186/s12985-021-01638-5.
5
The three facets of the SARS-CoV-2 pandemic during the first two waves in the northern, central, and southern Italy.意大利北部、中部和南部前两波 SARS-CoV-2 大流行的三个方面。
J Infect Public Health. 2023 Apr;16(4):520-525. doi: 10.1016/j.jiph.2023.02.002. Epub 2023 Feb 7.
6
The Italian national survey on Coronavirus disease 2019 epidemic spread in nursing homes.意大利关于 2019 年冠状病毒病在养老院中流行的全国性调查。
Int J Geriatr Psychiatry. 2021 Jun;36(6):873-882. doi: 10.1002/gps.5487. Epub 2021 Jan 2.
7
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy.SARS-CoV-2 的基因组流行病学研究揭示了意大利伦巴第大区的多种谱系和 SARS-CoV-2 感染的早期传播。
Nat Commun. 2021 Jan 19;12(1):434. doi: 10.1038/s41467-020-20688-x.
8
Impact of COVID-19 epidemics in paediatric morbidity and utilisation of Hospital Paediatric Services in Italy.2019年冠状病毒病疫情对意大利儿童发病率及儿科医院服务利用情况的影响
Acta Paediatr. 2021 Apr;110(4):1369-1370. doi: 10.1111/apa.15435. Epub 2020 Jul 24.
9
Diabetes mellitus is associated with 90-day mortality in old critically ill COVID-19 patients: a multicenter prospective observational cohort study.糖尿病与老年危重症 COVID-19 患者 90 天死亡率相关：一项多中心前瞻性观察队列研究。
Infection. 2023 Oct;51(5):1407-1415. doi: 10.1007/s15010-023-02001-2. Epub 2023 Mar 1.
10
COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak.COVID-19 在心移植受者中的表现：意大利北部疫情的多中心分析。
JACC Heart Fail. 2021 Jan;9(1):52-61. doi: 10.1016/j.jchf.2020.10.009. Epub 2020 Oct 29.

引用本文的文献

1
Risk of bias and certainty of evidence on the association between obesity and mortality in patients with SARS-COV-2: An umbrella review of meta-analyses.肥胖与 SARS-CoV-2 患者死亡率之间关联的偏倚风险和证据确定性：对荟萃分析的伞状综述。
Clin Nutr ESPEN. 2023 Feb;53:13-25. doi: 10.1016/j.clnesp.2022.08.014. Epub 2022 Aug 17.
2
Metabolic risk factors and risk of Covid-19: A systematic review and meta-analysis.代谢风险因素与 COVID-19 风险：系统评价和荟萃分析。
PLoS One. 2020 Dec 15;15(12):e0243600. doi: 10.1371/journal.pone.0243600. eCollection 2020.

本文引用的文献

1
The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak.在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫情期间重症监护病房（ICU）中糖尿病护理定制的必要性。
Diabetes Ther. 2020 Jun;11(6):1191-1193. doi: 10.1007/s13300-020-00824-y. Epub 2020 Apr 29.
2
COVID-19 and diabetes management: What should be considered?2019冠状病毒病与糖尿病管理：应考虑哪些方面？
Diabetes Res Clin Pract. 2020 May;163:108151. doi: 10.1016/j.diabres.2020.108151. Epub 2020 Apr 17.
3
Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?
在新冠疫情期间是否应重新考虑抗糖尿病药物？
Diabetes Res Clin Pract. 2020 May;163:108146. doi: 10.1016/j.diabres.2020.108146. Epub 2020 Apr 10.
4
COVID-19 and diabetes: Knowledge in progress.新型冠状病毒肺炎与糖尿病：知识在不断更新。
Diabetes Res Clin Pract. 2020 Apr;162:108142. doi: 10.1016/j.diabres.2020.108142. Epub 2020 Apr 9.
5
COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used).意大利糖尿病患者的新冠肺炎感染情况：对我们未来的启示（一次可供借鉴的经验）
Diabetes Res Clin Pract. 2020 Apr;162:108137. doi: 10.1016/j.diabres.2020.108137. Epub 2020 Apr 4.
6
COVID-19 and diabetes: Can DPP4 inhibition play a role?2019冠状病毒病与糖尿病：二肽基肽酶4抑制作用能否发挥作用？
Diabetes Res Clin Pract. 2020 Apr;162:108125. doi: 10.1016/j.diabres.2020.108125. Epub 2020 Mar 26.
7
Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China.在中国武汉，新冠肺炎糖尿病患者需要更好的血糖管理。
Metabolism. 2020 Jun;107:154216. doi: 10.1016/j.metabol.2020.154216. Epub 2020 Mar 24.
8
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
9
Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed.2019年新型冠状病毒病（COVID-19）疫情期间急需及时进行血糖管理。
Diabetes Res Clin Pract. 2020 Apr;162:108118. doi: 10.1016/j.diabres.2020.108118. Epub 2020 Mar 13.
10
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.